Zhang C, Hsueh W, Caplan M S, Kelly A
Department of Pathology, Children's Memorial Hospital, Chicago, IL 60614.
Crit Care Med. 1991 Aug;19(8):1067-72. doi: 10.1097/00003246-199108000-00016.
The mechanism of ischemic bowel necrosis induced by platelet-activating factor is unclear. Since intestinal hypoperfusion is observed after platelet-activating factor injection, we hypothesized that mesenteric vasoconstriction is the mechanism of bowel injury. The present study investigated the effects of saline infusion on platelet activating factor-induced bowel necrosis and its mechanism. Male Sprague-Dawley rats were divided into four groups: group A consisted of sham-operated rats; group B received platelet-activating factor (1.5 micrograms/kg iv); group C received platelet-activating factor and saline (0.097 mL/min iv); group D received platelet-activating factor and WEB 2086 (platelet-activating factor antagonist).
Saline infusion largely reversed platelet activating factor-induced hypotension, hemoconcentration, and reduction of the superior mesenteric arterial blood flow. Saline infusion also ameliorated platelet activating factor-induced bowel injury, although a mild-to-moderate degree of necrosis still developed focally. In addition, saline prevented the platelet activating factor-induced increase in intestinal platelet-activating factor production. Saline also prevented the increase in intestine leukocyte number, as estimated by myeloperoxidase activity.
Saline infusion is an effective treatment for platelet activating factor-induced shock and intestinal necrosis. However, focal bowel injury is still observed, suggesting that other factors besides hemodynamic changes contribute to the development of tissue injury. We also showed that, in vivo, platelet-activating factor stimulates its own synthesis via a positive feedback loop, which could be blocked by intravascular volume expansion with saline.
血小板活化因子诱导肠缺血性坏死的机制尚不清楚。由于注射血小板活化因子后可观察到肠道灌注不足,我们推测肠系膜血管收缩是肠道损伤的机制。本研究探讨了输注生理盐水对血小板活化因子诱导的肠坏死的影响及其机制。将雄性Sprague-Dawley大鼠分为四组:A组为假手术大鼠;B组静脉注射血小板活化因子(1.5微克/千克);C组静脉注射血小板活化因子和生理盐水(0.097毫升/分钟);D组静脉注射血小板活化因子和WEB 2086(血小板活化因子拮抗剂)。
输注生理盐水在很大程度上逆转了血小板活化因子诱导的低血压、血液浓缩和肠系膜上动脉血流量减少。输注生理盐水也改善了血小板活化因子诱导的肠道损伤,尽管仍有局灶性轻至中度坏死发生。此外,生理盐水可防止血小板活化因子诱导的肠道血小板活化因子生成增加。生理盐水还可防止肠白细胞数量增加,这是通过髓过氧化物酶活性评估的。
输注生理盐水是治疗血小板活化因子诱导的休克和肠坏死的有效方法。然而,仍观察到局灶性肠道损伤,这表明除血流动力学变化外,其他因素也有助于组织损伤的发展。我们还表明,在体内,血小板活化因子通过正反馈回路刺激其自身合成,而这可被生理盐水进行血管内容量扩张所阻断。